Interpretation of the Chinese Guidelines for Prevention and Control of Tuberculosis in Schools

doi:10.3969/j.issn.1000-6621.2021.06.004

Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (6): 542-545.doi: 10.3969/j.issn.1000-6621.2021.06.004

• Interpretation of Standards • Previous Articles Next Articles

Interpretation of the Chinese Guidelines for Prevention and Control of Tuberculosis in Schools

CHEN Hui, ZHANG Hui, CHENG Jun()

National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China

Received:2021-03-08 Online:2021-06-10 Published:2021-06-02
Contact: CHENG Jun E-mail:chengjun@chinacdc.cn

Abstract

Abstract:

In order to guide the prevention and control of tuberculosis in schools and reduce the spread of tuberculosis in schools, the National Health Commission and the Ministry of Education organized experts to formulate and published “Chinese Guidelines for Prevention and Control of Tuberculosis in Schools”. Based on the practical experience and relevant technical strategies development in recent years, the prevention and control measures are further standardized and detailed in this guidelines, and the necessary forms and cards are attached, which is instructive and operational. The author describes the formulation background, main contents and characteristics of guidelines, to improve the relevant personnel’s ability of tuberculosis prevention and control in schools

Key words: Schools,students, Tuberculosis control and prevention, Guideline

CHEN Hui, ZHANG Hui, CHENG Jun. Interpretation of the Chinese Guidelines for Prevention and Control of Tuberculosis in Schools[J]. Chinese Journal of Antituberculosis, 2021, 43(6): 542-545. doi: 10.3969/j.issn.1000-6621.2021.06.004

References 9

[1]	中华人民共和国卫生部办公厅, 中华人民共和国教育部办公厅. 关于印发《学校结核病防控工作规范(试行)》的通知. 卫办疾控发〔2010〕133号. 2010-08-06.
[2]	中华人民共和国国家卫生和计划生育委员会办公厅, 中华人民共和国教育部办公厅. 关于印发学校结核病防控工作规范(2017版)的通知. 国卫办疾控发〔2017〕22号. 2017-07-07.
[3]	中华人民共和国国家卫生健康委员会办公厅, 中华人民共和国教育部办公厅. 关于印发中国学校结核病防控指南的通知. 国卫办疾控函〔2020〕910号. 2020-10-16..
[4]	王前, 李涛, 杜昕, 等. 2015—2019年全国肺结核报告发病情况分析. 中国防痨杂志, 2021,43(2):107-112. doi: 10.3969/j.issn.1000-6621.2021.02.002. doi: 10.3969/j.issn.1000-6621.2021.02.002
[5]	陈卉, 夏愔愔, 张灿有, 等. 2014—2018年全国学生肺结核疫情变化趋势及特征分析. 中国防痨杂志, 2019,41(6):662-668. doi: 10.3969/j.issn.1000-6621.2019.06.013. doi: 10.3969/j.issn.1000-6621.2019.06.013
[6]	Zhang M, Wang T, Hou S, et al. An Outbreak of Multidrug-Resistant Tuberculosis in a Secondary School—Hubei Province,2019. China CDC Weekly, 2019,1(5):67-69. doi: 10.46234/ccdcw2019.020. doi: 10.46234/ccdcw2019.020 URL
[7]	Wang S, Cui Y, Liu N, et al. A Tuberculosis Outbreak at a School—Xinjiang Uygur Autonomous Region, China, 2019. China CDC Weekly, 2020,2(46):881-883. doi: 10.46234/ccdcw2020.240. doi: 10.46234/ccdcw2020.240 URL
[8]	Chen H, Xia Y, Zhang C, et al. Tuberculosis in Schools and Requirements for Prevention and Control in China. China CDC Weekly, 2021,3(3):58-60. doi: 10.46234/ccdcw2021.005. doi: 10.46234/ccdcw2021.005 URL
[9]	王黎霞, 成诗明, 陈伟. 学校结核病防治工作手册. 北京: 军事医学科学出版社, 2012.

Interpretation of the Chinese Guidelines for Prevention and Control of Tuberculosis in Schools

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 9

Related Articles 6

Recommended Articles

Metrics

Comments

[1]	FENG Ying, REN Fei. Interpretation of Clinical Guidelines for the management of Rifampicin-resistant Tuberculosis in South Africa (2019) and its comparison with Guidelines for Drug-resistant Tuberculosis Chemotherapy in China (2019) [J]. Chinese Journal of Antituberculosis, 2021, 43(3): 295-298.
[2]	Beijing Chest Hospital, Capital Medical University, Clinical Trial Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis . Guideline for clinical application of cycloserine in the treatment of tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(6): 533-540.
[3]	Beijing Chest Hospital,Capital Medical University, Clinical Trial Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Guideline for clinical application of clofazimine in the treatment of tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(5): 409-417.
[4]	WANG Ze-ming, SUN Lin, SHEN A-dong. Current status and thinking of clinical practice guidelines of tuberculosis in children [J]. Chinese Journal of Antituberculosis, 2020, 42(10): 1025-1028.
[5]	LIU Yi-dian,GUI Xu-wei,SHEN Xiao-na,YU Yuan-yuan,YAO Lan,LOU Hai,SHA Wei,XIAO He-ping. Interpretation of “An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline:Treatment of Drug-Resistant Tuberculosis” and comparison with “Guideline for Chemotherapy of Drug Resistant Tuberculosis(2019)” in China [J]. Chinese Journal of Antituberculosis, 2020, 42(1): 12-16.
[6]	Er-yong LIU,Lin ZHOU,Li-xia WANG. Comprehensive interpretation of the Classification of tuberculosis (WS 196-2017) [J]. Chinese Journal of Antituberculosis, 2018, 40(3): 234-238.